Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The eukaryotic translation machinery is the complex macromolecular apparatus responsible for protein synthesis, comprising the 80S ribosome (composed of 40S and 60S subunits) and various auxiliary proteins known as translation factors [Source: NIH/NCBI]. This machinery decodes genetic information from mRNA into functional polypeptides, a process essential for cellular growth, differentiation, and homeostasis. In many diseases, particularly cancer and viral infections, this machinery is hijacked or dysregulated to favor the production of oncogenic or viral proteins over host cell maintenance [Source: PubMed, Nature]. For instance, viruses like SARS-CoV-2 rely entirely on the host's ribosomes for replication, while many tumors overexpress initiation factors like eIF4E to drive proliferation [Source: Science, Journal of Clinical Oncology]. Consequently, components of this machinery have become significant therapeutic targets, with drugs like zotatifin and plitidepsin designed to disrupt specific stages of the translation cycle. However, because protein synthesis is a fundamental biological process, targeting it requires high specificity to avoid severe systemic toxicity and maintain a viable therapeutic index [Source: Nature Reviews Drug Discovery].
Inhibition of protein synthesis by targeting various stages of translation, including initiation (e.g., eIF4A/eIF4E inhibition), elongation (e.g., eEF1A inhibition), or the ribosome's peptidyl transferase center [Source: Nature, Science].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation machinery (80S ribosome) (80S ribosome).